B

Biocytogen Pharmaceuticals Beijing Co Ltd
HKEX:2315

Watchlist Manager
Biocytogen Pharmaceuticals Beijing Co Ltd
HKEX:2315
Watchlist
Price: 26.4 HKD -2.37% Market Closed
Market Cap: 10.5B HKD

Wall Street
Price Targets

Price Targets Summary
Biocytogen Pharmaceuticals Beijing Co Ltd

There are no price targets for Biocytogen Pharmaceuticals Beijing Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Biocytogen Pharmaceuticals Beijing Co Ltd Competitors:
Price Targets
KALV
Kalvista Pharmaceuticals Inc
87% Upside
301207
Hualan Biological Bacterin Inc
2% Upside
URGN
Urogen Pharma Ltd
57% Upside
688278
Xiamen Amoytop Biotech Co Ltd
21% Upside
ATRA
Atara Biotherapeutics Inc
3% Downside
BMRN
Biomarin Pharmaceutical Inc
78% Upside
BVXP
Bioventix PLC
134% Upside

Revenue
Forecast

Revenue Estimate
Biocytogen Pharmaceuticals Beijing Co Ltd

For the last 3 years the compound annual growth rate for Biocytogen Pharmaceuticals Beijing Co Ltd's revenue is 40%. The projected CAGR for the next 3 years is 24%.

40%
Past Growth
24%
Estimated Growth
Estimates Accuracy
1%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Biocytogen Pharmaceuticals Beijing Co Ltd

The compound annual growth rate of Biocytogen Pharmaceuticals Beijing Co Ltd's operating income for the next 3 years is 38%.

N/A
Past Growth
38%
Estimated Growth
Estimates Accuracy
24%
Average Beat

Net Income
Forecast

Net Income Estimate
Biocytogen Pharmaceuticals Beijing Co Ltd

The compound annual growth rate of Biocytogen Pharmaceuticals Beijing Co Ltd's net income for the next 3 years is 112%.

N/A
Past Growth
112%
Estimated Growth
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Biocytogen Pharmaceuticals Beijing Co Ltd's stock price target?
Not Available

Biocytogen Pharmaceuticals Beijing Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Biocytogen Pharmaceuticals Beijing Co Ltd's Revenue forecast?
Projected CAGR
24%

For the last 3 years the compound annual growth rate for Biocytogen Pharmaceuticals Beijing Co Ltd's revenue is 40%. The projected CAGR for the next 3 years is 24%.

What is Biocytogen Pharmaceuticals Beijing Co Ltd's Operating Income forecast?
Projected CAGR
38%

The compound annual growth rate of Biocytogen Pharmaceuticals Beijing Co Ltd's operating income for the next 3 years is 38%.

What is Biocytogen Pharmaceuticals Beijing Co Ltd's Net Income forecast?
Projected CAGR
112%

The compound annual growth rate of Biocytogen Pharmaceuticals Beijing Co Ltd's net income for the next 3 years is 112%.

Back to Top